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Abstract. The yield of several commodity crops is provided in large part by genetically 
modified crops in North and South America. However, reservations exist in Europe due 
to possible negative effects on human health or environment. This paper aims to ana-
lyse the current research priorities identified in EU countries and to engage European 
stakeholders into the formulation of future common research needs regarding the effects 
of the possible adoption of commercially available and forthcoming genetically modi-
fied organisms (GMOs) in the areas of socio-economics, human and animal health, 
and environment. Additionally, it aims to identify the requirements for sharing avail-
able research capacities and existing infrastructures. First a mapping exercise of existing 
research activities in Europe was performed. A questionnaire was developed on a web-
based platform and submitted to national focal points to collect information from EU 
Member States. Information was collected from 320 research projects conducted in the 
last 10 years in Europe. To refine results of the surveys, twenty invited experts and stake-
holders from the public funding agencies of different EU Member States participated in 
an international workshop. This paper reports the main findings of these activities. 
Keywords. Genetically modified organisms (GMOs), socio-economic, human and 
animal health, environment, workshop
JEL codes. Q16, Q55, O30
1. Introduction
Scientific and technological progress in agriculture has resulted in innovations that 
have contributed to increase production and productivity. Genetically modified (GM) 
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crops have shown an extremely rapid adoption rate in many areas of the world. About 12 
percent (179.7 million of 1.5 billion hectares) of global cropland was invested with GM 
crops in 2015 (James, 2015). Maize area summed up to 53.7 million hectares in 2015 and 
GM soybean was cultivated over 92 million hectares during the same cropping season. 
Herbicide tolerance (HT) crops occupy 100 million ha, insect resistant (IR) 26 million ha 
and crops expressing stacked HT and IR traits were planted on 45 million ha. However 
at the same time, in different world areas genetically modified organisms (GMOs) have 
experienced a transnational opposition from different interests groups (Herring, 2008). 
Opposition to transgenic crops has often argued the lack of sufficient scientific data dem-
onstrating that GM crops are harmless to humans and to the environment (Rausser et al., 
2015; Yang and Chen, 2016). Although these uncertainties about food and feed products 
derived from plant breeding is not confined to transgenic plants (Herring, 2008) and that, 
beyond transgenic plants, alternative methods are being applied to obtain new crop varie-
ties (Parisi et al., 2016), GMOs are often questioned in regards of the uncertainty of their 
possible risks. Schurman and Munro (2010) describe how these concerns gained consen-
sus in a network of stakeholders, including consumer, environmental, and social-justice 
organizations. The European Union has endorsed the precautionary principle and there-
fore in its risk assessment a central role is sought in addressing and dealing with these 
uncertainties. The EU regulations on GMOs constitute a salient issue of risk governance 
given the politically high visibility of the topic (Drott et al., 2013). The EU regulatory 
framework on GMOs includes rules on authorization conditions, traceability, labelling, 
segregation, co-existence, which are established by the European Commission based on 
the risk assessment procedures conducted by the European Food Safety Authority (EFSA) 
which provides independent scientific advice on this topic (Drott et al., 2013). According-
ly, scientific research promoted by the European Commission so far has also been framed 
considering the (potential) positive and negative effects of GMOs. 
Despite the global opposition, transgenic crops have spread rapidly in the agribusi-
ness, and the number of GM events at the commercial cultivation, precommercial or reg-
ulatory stages has more than doubled between 2008 and 2014 (Parisi et al., 2016). The 
uneven adoption rate of GM crops is still evident. US continues to be the lead country 
with 70.9 million hectares (ca 40% of global) with about 90% adoption for the principal 
crops: maize, soybean and cotton (James, 2015). While GM plants currently available fea-
ture a limited set of different traits, there are several crops with novel traits in the regu-
latory pipeline and at late stages of research and development (R&D) (e.g., resistance to 
viruses and pests, tolerance to drought, modified chemical composition, enhanced nutri-
tional content, etc.) (National Academy of Science, Engineering and Medicine, 2016). Cul-
tivation in the EU has remained limited to Bt-maize that in 2013 has been cultivated in 
almost 150,000 hectares mainly in Spain (137,000 ha), followed by Portugal, the Czech 
Republic, and Romania and Slovakia (European Commission, 2015). However, five new 
GM events for cultivation are currently being examined by EU Commission for a possible 
imminent approval. At the same time, the number of experimental field release trials has 
seen a continuous decline over the last years (Gómez-Galera et al., 2012).
It is notable that although a plethora of research projects have been conducted result-
ing in scientific publications which examine the impacts of GM crops on the receiving 
environments, on animal and human health, and on the functioning of farms, markets and 
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rural communities, the technology is still controversial on a number of levels. There is a 
large body of scientific evidence suggesting that, although there are still reasons for concern 
and associated risks which must be carefully assessed (e.g., crop failures, price increases, 
seed market monopolisation and farmers’ dependency on a few technology providers, co-
existence with non-GM crops, negative impacts on non-target organisms, and resistance 
development in target pest populations, etc.), when managed and used appropriately GM 
crops may provide notable benefits (e.g., reduced use of pesticides, implementation of no-
till agriculture which sequesters carbon and builds up exhausted soils, increased harvests, 
revenues and profits for farmers, reduced mycotoxin content in harvested maize, etc.) (Bar-
am and Bourrierm, 2011; Graef et al., 2012; Mora et al., 2012; Jacobsen et al., 2013; Devos 
et al., 2014; Mannion and Morse, 2012). At the same time, there is also a growing body 
of completed and on-going scientific programmes specifically dedicated to the assessment 
of the potential socio-economic, environmental and health effects of the use of GM crops 
within both Europe and globally (European Commission, 2010). 
Given the number of research initiatives, it is important to focus the available resourc-
es for research on the most critical gaps in our knowledge, so that more informed regula-
tory and policy decisions can be made in the future. This means, at the EU level, to sig-
nificantly enhance the alignment of the research programmes of the individual Member 
States, identifying knowledge gaps and capacity building needs, in order to avoid duplica-
tion of work in these areas, to leverage complementarities, and to enhance coordination 
between scientists from all over Europe. This should be done improving the engagement 
of stakeholders (e.g., industry, farming organisations, civil society organisations – CSO, 
non-governmental organisations – NGOs, EU and national competent authorities, fund-
ing organisations, academia, etc.) in the shaping of future research agendas and pro-
grammes, in order to make these research programmes more meaningful to the end-users 
of the scientific results, and to increase legitimisation of research trajectories and owner-
ship (Ross, 2007; Noteborn and van Duijne, 2011; Graef et al., 2012). The involvement of 
stakeholders in the identification of risks and concerns is believed to have a key role in 
the process of technology evaluation. The use of GMOs is given as an example for con-
tested innovation in the EU, which failed to take into consideration the ethical concerns, 
uncertainties and risks at an early stage of the technology development (van den Hoven, 
2013). Although the use of GM crops in agriculture remains greatly questioned in the EU, 
new varieties have been developed around the world, which may find their way into the 
EU market in the near future (Parisi et al., 2016). Genomic technologies have substan-
tially improved since the appearance of first cultivated GM crops, so that individual plant’s 
genome can be sequenced and analysed, genotyping methods have improved in through-
put and cost efficiency; thus, it is likely that additional traits can be introduced into cul-
tivated plants with increased efficiency and reduce costs associated with breeding. Such 
developments imply the need to steer the public research policy to invest its resources in 
better correspondence to the social concerns related to genetic technologies.
This paper is part of the PreSto GMO ERA-Net project1 aiming at creating and suc-
cessfully implementing an ERA-Net (European Research Area Network)2 that will coor-
1 PreSto GMO ERA-Net (Preparatory steps towards a GMO research ERA-Net), EU FP7, Grant agreement n. 
612739. See the website: http://www.presto-gmo-era-net.eu.
2 The objective of the ERA-NET scheme is to step up the cooperation and coordination of research activities 
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dinate research activities carried out at national or regional level in the Member States 
and the mutual opening of national and regional research programmes on the effects of 
GMOs in the areas of socio-economics, human and animal health, and the environment 
(Rauschen et al., 2015). In particular, this paper aims to identify knowledge gaps and 
future research needs on the effects of GMOs based on the analysis of the research priori-
ties and a dialogue with the stakeholders. We present the results of a mapping exercise of 
existing research activities on the effects of GMOs in Europe, and the main outcomes of 
an international workshop with relevant experts and stakeholders, European institutions, 
and CSOs held in Milan in November 2014.
2. Material and methods
2.1 Mapping of existing research activities
The first step was to provide an overview of existing research activities and knowl-
edge regarding the socio-economic, health, and environmental effects of GMOs in Europe. 
This was performed by an up-to-date mapping of national research programmes, projects, 
infrastructures, activities, research groups and capacities in the EU and internationally. The 
following GMO assessment databases or datasets were used in mapping existing research 
activities: SCAR-Collaborative Working Group “GMO Risk Research” (SCAR-CWG, 2012), 
the BiosafeRes database3, and the European Commission’s compendium summarizing the 
results of 50 GMO research projects, co-funded by the EC and conducted in the period 
2001-2010 (European Commission, 2010). The data were integrated and updated with a 
questionnaire developed on a web-based platform (the CADIMA4 database) and submit-
ted to national focal points to collect information from Member States (Moyankova and 
Kostov, 2015). Through the questionnaire it was possible to collect details describing 
recent and ongoing projects examining the GMO effects, such as the thematic area of the 
research, the sources of funding and the type of organizations that carried out the research. 
The questionnaire was designed in a specialized section of the CADIMA database for col-
lection of data about the recent and ongoing GMO assessment projects. The projects were 
characterized by one reviewer according to several categories including: 
a. type of funding (government, EU funding, industry, other);
b. type of project leading organization (research/academy, individual, private company, 
other);
c. regional level of the project consortium (national, international EU, international 
beyond EU);
d. type of organizations in the project consortium (industry, research/academy, govern-
carried out at national or regional level in the Member States and Associated States through the networking 
of research activities conducted at national or regional level, and the mutual opening of national and regional 
research programmes.
3 The BiosafeRes database is a worldwide, web-based, free and public-access database of past and current 
research projects in GMO Biosafety, is improving communication within the scientific community, and thus 
clearly facilitates development of more and better worldwide collaborative research ventures in this field by 
encouraging synergy. Available at: http://biosaferes.icgeb.org. 
4 Central Access Database for Impact Assessment of Crop Genetic Improvement Technologies, see the website: 
http://www.cadima.info.
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ment, other, or mix of them); 
e. type of GMO analysed in the project (GM plant, GM animal, GM micro-organisms);
f. main topic of GMO impact assessment (environment, animal health, human health, 
technology/society, other); 
g. sub-topics of impact assessment (e.g., for environment: soil, water, air, biodiversity, 
plant pest and diseases, geochemical variables, landscape structure, target effects, non-
target effects, other).
2.2 The stakeholder engagement approach
Starting from the results of the mapping exercise, the objective of the international 
workshop held in Milan on November 24th, 2014, was to use a transparent and structured 
approach for recommending a list of transnational research needs regarding the effects of 
GMOs in the areas of socio-economics, human and animal health, and environment, as 
well as requirements for sharing of available research capacities and existing infrastruc-
tures. The focus of the workshop was on GM crops or other applications (e.g., animals, 
micro-organisms, etc.) on the marketplace or near to be commercialized, not necessarily 
in the EU, but that may have effects in the EU. Applications intentionally released into 
the environment and/or used immediately in feed and food applications were considered. 
A Stakeholder Engagement Protocol was agreed with project partners to clarify workshop 
aims, activities, and research question development (Menozzi et al., 2014). The stakehold-
er involvement process began with the generation of a “Potential Stakeholder Database”. 
The experts were specifically selected based on their career, successfully achievements 
and long-standing expertise in the field of GMOs related to scientific, economic, social 
and policies aspects. In addition, a broadest group of stakeholders in different fields were 
added in the database, including representative leaders of farmer’s organizations, public 
authorities and agencies, EU research Institutions, private companies and other relevant 
stakeholders. A preliminary list was sent to the project partners and integrated with their 
suggestions. Then, the experts and stakeholders were contacted following a step-by-step 
criteria in order to have a right balance between the three scientific areas, as well as a fair 
representation of the Member States. A registration before the deadline was required in 
order to define the number of participants, their role and activities, to guarantee the right 
balance of the attendees. 
Forty-five stakeholders were invited to represent a right balance of expertise between 
the three areas (i.e. socio-economics, human and animal health, and environment), organ-
izational perspective (academic, Member State and EU agency, CSO communities) and 
geographical areas. The international workshop activities, conducted by three facilitators 
of the University of Parma, were divided into two sections. The morning session was dedi-
cated to share and discuss preliminary results of the project with the participants, includ-
ing the results of the mapping of existing research activities. In the afternoon session the 
participants were divided into three working groups, based on the area of expertise or 
interest, to identify the relevant transnational research needs. The three working groups 
used a structured multi-stage approach, consisting in six steps. Steps from 1 to 5 aimed at 
populating the list of transnational research needs (Figure 1), while Step 6 consisted in the 
identification of capacity/infrastructure needs to cover those research needs. 
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Figure 1. Flow chart for identifying a list of future research needs by the stakeholders.
Stage 1. A questionnaire was sent two weeks before the workshop to all the experts 
and stakeholders to identify the main research questions across GM species/traits and 
effects. Based on their replies to the questionnaire, a structured dataset of initial research 
questions was populated. 
Stage 2. Participants in each working group were encouraged to submit modifica-
tions to existing research questions or add new ones, given the evidence provided by the 
mapping of existing research activities. The initial dataset of research questions was then 
established. 
Stage 3. Each working group reviewed the initial dataset of research questions on its 
area of expertise discussing whether an existing solution to the research need exists and 
was available. If this was the case, the use of research outcomes already undertaken was 
recommended. 
Stage 4. If the research need was not investigated so far, or if the results were not 
already available or applicable, the experts considered if it was on the European agenda or 
not. If yes, an EU funded project was more appropriate and therefore recommended. 
Stage 5. If the research need was not on the current EU agenda, the experts checked 
if it could be defined as a transnational interest. If yes, then a programme funded transna-
tionally by the ERA-Net was a likely solution (transnational research need); otherwise, if it 
was only on a national agenda, then a national project or programme was suggested. 
Stage 6. Once the list of transnational research needs was populated, the moderator 
asked participants which capacity/infrastructure needs were available in order to cover 
those transnational research needs.
A trained facilitator conducted the discussion in each working group. Potential disagree-
ments were discussed, and eventually reported as such. All inputs from the working groups 
were presented in the plenary session, including the areas of persistent disagreements.
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3. Results: existing research activities on GMOs in Europe 
Information about 320 projects on existing research activities regarding the techno- 
and socio-economic, health, and environmental effects of GMOs in Europe were collected 
through the mapping exercise (Moyankova and Kostov, 2015). The data included the type 
of organizations leading the projects, the funding source, the topics of the GMO assess-
ment projects (human health, animal health, environment, technological/social), and the 
studied GMO species. Unfortunately, it was not possible to collect consistent information 
about the projects’ budget and timing. This may have introduced a bias since it was not 
possible to evaluate the projects’ relative importance and achieved results. Nevertheless, 
the number and type of projects alone provides a valid mapping of current research activi-
ties to be used as a starting point for the purposes of the study.
The surveyed GMO projects in Europe have started between 1989 and 2010. Most of 
the projects (85%) were led by research or academy organizations such as universities, insti-
tutes or research centers. A relatively small portion of the projects were led by government 
organization and private companies, accounting for only 9% and 5% respectively. Most of 
the projects were carried out at national level (198 projects). International collaboration was 
predominantly among European countries (80 projects), while only 27 projects included 
countries outside Europe. A number of 15 projects did not provide this information. 
The GMO projects were led by institutions in different European countries. When 
considering the number of GMO projects per million capita inhabitants, Austria is on 
leader position with 6.0 projects per million capita, followed by Denmark (3.1), Norway 
(2.8), Finland (2.3), Ireland (1.4), Hungary (1.2) and Belgium (1.1). The other countries, 
i.e. France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland and United 
Kingdom, have less than 1 project per million capita. The EU is the only funding source 
for projects leaded by Greek and Irish organizations, while other organizations based in 
Hungary, Sweden and Switzerland had only projects funded by national sources (Fig-
ure 2). Seven of the project leader countries are funded mainly by governments, namely 
UK, Spain, Norway, Italy, Germany, Finland and Austria. The EU was the major funding 
source for project leaders based in the Netherlands, Denmark, France and Belgium. 
Not surprisingly, projects were mostly focusing on GM plants (196 projects, 68% of 
the total, Figure 3). GM micro-organisms and GM animals were analysed only in 20 (6%) 
and 10 (3%) projects, respectively. A few projects (7) were dealing with GM plants and 
micro-organisms at the same time. Many projects did not specify the type of GMO that 
was analysed (n=65, 20%). The interaction of GMO with the environment was investigat-
ed in more than a half of the projects (52%, Figure 3). One third of the projects (33%) 
were dealing with the developments of new methods, tools for detection in and analyses 
of food and feed, methods for risk assessments, new technique, etc. The effect of GMOs 
on human and animal health is a topic of interest in 10% and 4% of the projects, respec-
tively. Many projects covered several topics at the same time. The main subjects (environ-
ment, human health, animal health and technology/society) showed the same distribution 
when crossed by type of studied GMOs (Figure 3). 
Biodiversity preservation is the predominant sub-topic (58%) in the projects studying 
the interaction of GMOs with the environment (Table 1). The effect on non-target spe-
cies was analysed in 25% of the projects. Other sub-categories were objects of only few 
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projects. Among the different types of GMOs, the GM crops are the most investigated for 
their effect on the environment (Table 1). The technological and socio-economic aspects 
of the GMOs were analysed in 120 projects. Development of new methods for GMO 
detection and technological innovation were predominantly studied in 76% of these pro-
jects. Among the socio-economic issues, the economic efficiency was studied the most, 
followed by consumer demand and food security (Table 1). Many projects covering this 
Figure 2. Number of GMO projects by funding source (EU, Government, Industry and other funding 
source) in Europe per country (n = 305).






















Figure 3. Type of analysed GMOs and main topics (n = 320*).











Source: own elaboration. * Note: Many projects covered more than one topic.
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topic did not specify the type of GMO and this hampered the data analysis. Fewer pro-
jects treated the effects of GMOs on human health (Table 1). Food safety and allergenicy 
were the most explored sub-topics in particular for GM crops. The effect of GMOs on ani-
mal health was explored in 15 projects, where feed safety was the only subject analysed. 
GM crops interaction with human and animal health was the most studied topic, whilst 
GM animals impact was analysed in only one project. Considering the country of the 
leading organization, Switzerland and Spain had projects that only dealt with the effects 
of GMOs on the environment. This subject was the most studied in 7 project leader coun-
tries, namely UK, Sweden, Ireland, France, Finland, Denmark and Austria. Organizations 
from Belgium, Italy and Norway were leading mainly projects about technology and social 
effect of GMOs. GMOs safety for human health is relatively more studied in 2 countries, 
i.e. Hungary and Greece. The less studied subject was the effect of GM feed on animal’s 
health. Only 5 countries were leading few projects about this topic, the most relevant of 
which was Hungary.










Food safety 17 1 1 - 4 23
Feed safety 13 - - - 2 15
Allergenicity 5 - - - - 5
Toxicity 3 - - - - 3
Therapeutic use 1 1 - - - 2
Nutritional value 2 - - - - 2
Total Health 41 2 1 0 6 50
Biodiversity 67 11 2 4 14 98
Non-target effects 39 - - 2 1 42
Soil 8 2 - 1 1 12
Target effects 6 - 3 - - 9
Plant pest and diseases 6 - - - - 6
Other effects 2 - - - - 2
Total Environment 128 13 5 7 16 169
Economic efficiency 11 - - 1 2 14
Consumer demand 1 - - 1 9 11
Food security 2 - - - - 2
Other effects - - - - 2 2
Total Socio-Economics 14 0 0 2 13 29
Innovative technology 53 7 4 1 18 83
Technical application 5 - - - 3 8
Total Technology 56 7 4 1 21 91
Total 241 22 10 10 55 339
Source: own elaboration. * Note: Many projects covered more than one topic. 
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4. Results: stakeholders view on the future research needs
4.1 Workshop participants
Of the total 45 experts contacted for participating in the international workshop, a 
final number of 20 individuals participated in the activities (Table 2); Powers et al. (2014) 
suggested that a number between 20 and 25 gives a right balance between the diversity of 
technical and sector perspectives and fluid working relationships. 
Table 2. Workshop contracted persons and participants per category.
Category Contacted persons Participants Participation rate
Expert Environment 11 7 64%
Expert Socio-Economics 4 4 100%
Expert Health 7 2 29%
Stakeholders 14 2 14%
European Institutions 4 1 25%
Funding Bodies 5 4 80%
Total 45 20 44%
The experts studying the environmental effects of GMOs were the most represented, 
followed by the socio-economic experts. The participants were 44% of total the number 
of contacted persons. Although a fair gender balance was taken into consideration in 
contacting the experts, males were more represented than women in the final group of 
participants (75% males). The weakest participation was found among the stakeholders 
(14%), whilst the highest rate was found among the socio-economic experts (100%), then 
the environmental (64%) and finally among the health (29%). The participants originat-
ed from ten European countries (Italy 3, Germany 3, The Netherlands 2, Austria 2, UK 
2, Swiss 1, Spain 1, Denmark 1, Bulgaria 1, Romania 1); three stakeholders represented 
European organizations/institutions (i.e., COPA/Cogeca, the Public Research & Regula-
tion Initiative – PRRI –, and the European Food Safety Authority – EFSA). The career 
stage of the participants was quite homogeneous, since most of them were in a senior 
position, leaders of research units or project leaders. As observed by Schneider and Gill 
(2016) having both young and senior researchers in the same group could discourage 
some participants to express their views, leading seniors to control the discussion with 
their point of view. 
4.2 Initial dataset of research questions 
The initial dataset of research questions to consider in developing research needs, as 
resulted from stages 1) and 2) (see Section 2.2), have been categorised across the subject 
areas (i.e. socio-economics, human and animal health, and environment), and species/
traits (i.e. GM crops, insects, animals, micro-organisms and all GMOs). Thus, defined cat-
egories of questions were aligned with the results from the mapping exercise to identify 
67Stakeholder engagement: identifying future directions for GMO research
potential gaps in the research that has been done so far, and the future research directions 
considered relevant by the stakeholders. Table 3 provides a synthetic representation of the 
initial research needs considered by the experts in their deeper analysis. 
A list of 48 research questions was developed by the experts in the socio-economic 
area. The identified projects in the mapping of current research activities (see Table 1, Sec-
tion 3) are related mainly to the economic efficiency and consumer demand. Similarly, the 
stakeholders consider important the general economic effects, such as the costs and the 
profitability, but also more specific subjects like the economics of segregation/co-exist-
ence, legislative framework, consumers perception and attitudes, macro-economic, yields, 
and other effects (Table 3). Most of them were considered for all GMOs and GM crops 
in general, or insect resistant (IR) crops and herbicide tolerant/herbicide resistant (HT/
HR) crops. For instance, the experts considered the necessity to include ‘non-pecuniary’ 
benefits in the analysis of costs savings related to HT and IR crops (e.g., off-farm income, 
management time saving, labour flexibility, equipment cost savings, better standability, 
etc.), to improve the methodology to analyse the segregation rules of GMOs (e.g., the wel-
fare effects of labelling and segregation policy), and to evaluate the economic effects of 
relatively less widespread varieties, such as virus-resistant cassava and Golden rice. Only 
one research question was identified by the workshop participants for species other than 
crops: the assessment of the socio-economic impact of GM animals. The large portion of 
research questions in the initial dataset defined by the stakeholder are specific to differ-
ent types of GM crops which already exist on the market or are under development. GM 
plants and crops are also subjects of many projects identified during the mapping exer-
cise (Table 1). Since new GM crops and traits are under development outside the EU, and 
potentially access to the common market in the next future, the experts and stakeholders 
have suggested to concentrate research efforts on vegetable species. 
The European research carried out so far in the area of human and animal health is 
primary related to the safety of GM food and feed (Table 1). During stages 1) and 2) a 
number of 25 research needs were identified in the area of health (Table 3), divided into 
the main effects food and feed safety, nutritional value, allergenicity, toxicity and other. 
For instance, the experts considered the need to assess the positive health effects of the 
reduced fumonisin content in IR crops. It was argued that GM crop unintentionally pro-
duce high amount of toxic substances, e.g. acetylated aspartic acid, and that animal will be 
the main users being exposed to such substances. Therefore, research is needed to focus 
on developing and validating a test protocol in livestock animals. Most of these research 
needs were considered for all GMOs, while none where identified for insects and other 
animals. This probably because it was stressed that the focus was on GMOs on the mar-
ket or near to be commercialized. These results indicate no substantial differences in the 
research carried out so far and the future research needs in the area of human and animal 
health as the questions related to the toxicity, allerginicity and food safety are still central 
for the novel applications of GMOs (Parisi et al., 2016). 
A number of 47 research needs were identify by the experts to cover the area of envi-
ronment (Table 3). Most of the projects carried out so far on the environmental impact 
of GMOs are dealing with biodiversity and non-target effects (Table 1). Questions related 
to the possible effects to biodiversity of the emerging crop varieties and traits are still of 
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are also pointed as important followed by the effects to plant pest and diseases, air, ecosys-
tem services, climate change, and other effects. Most of the research needs were identified 
for all GMOs, IR crops or other plants. For instance, stakeholders claimed to develop field 
methods to monitor soil process intensity and changes, to implement an application of 
environmental DNA to detect changes in biodiversity, and to evaluate the potential effects 
on non-targeted organisms (NTOs) and the possible protein interactions or synergistic 
effects of stacked events expressing Cry and Vip proteins. No research need was identified 
for GM insects or other animals. 
The initial dataset of research questions was provided to the workshop participant as 
a starting point, to support thinking about potential research needs that were outside their 
specific expertise area. The lists supplemented explicit encouragement to participants to 
think broadly about potential research areas. The activities of the three working groups 
have followed the structured multi-stage approach described in Figure 1. Each working 
group was arranged of 5/6 experts, one moderator and one note-taker, chosen among the 
project partners. The participants in each working group reached a relatively small list of 
research needs (from 14 to 18), also by individual questions into groups of questions that 
were similar or closely related. Consolidating individual questions into broader research 
areas was encouraged when they had similar implications for an assessment or subsequent 
risk management decision. The complete list of research needs is reported in Menozzi et 
al. (2014).
4.3 Socio-economic research needs
The “Socio-economic” working group identified several categories of research needs. 
According to the experts efforts are needed to develop a methodological framework for 
assessing the socio-economic effects of GMOs. This framework should be used to inform 
policy development. Socio-economic considerations are already included in the regulatory 
frameworks on GMOs of some countries (Binimelis and Myhr, 2016). However, it is nec-
essary to work to develop a robust framework and methodology, including criteria, indi-
cators, etc., capturing socio-economic considerations in biosafety decision-making. Gar-
cia-Yì et al. (2014) identified six topics, i.e. the farm-level economic impacts, the econom-
ics of co-existence, the economics of segregation at the supply chain level, the consum-
ers’ acceptance of GMOs, the environmental economics impact and the impacts of GMOs 
on food security. Thus, although there is a high interest in the implementation of socio-
economic considerations in biosafety regulations (Binimelis and Myhr, 2016), research is 
needed to establish a robust framework on the socio-economic impacts of GMOs, and 
methodology covering data gathering, assessment and decision making. 
From the supply chain point of view, Park et al. (2011) have estimated the revenue 
forgone by EU farmers due to on-going limited use of IR and HT crops. Similarly, the 
effects of the EU regulation on GMOs on EU competitiveness and on innovative research 
developed at the EU level should be assessed, as well as the welfare effects across different 
groups in society (e.g., farmers, consumers, etc.) in the context of different policy settings 
(e.g., labelling). For instance, the EU co-existence measures affect farmers differently across 
EU Member States according to the isolation distances (between GM and non-GM crops) 
required by different countries and for different species (Ramessar et al., 2010). An eco-
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nomic evaluation of the welfare distribution of flexible co-existence regulations may assist 
the adoption of proportionate measures (Devos et al., 2014). The stakeholders claimed 
that the effects of GMOs along the whole supply chain should be investigated further. This 
point goes beyond the common cost-benefit analysis; it considers how the structure of sup-
ply chains is affected by innovation, how the efficiency is impacted, how the horizontal/
vertical relationships could change, what are the implication on labour market, etc. Up to 
now, research mostly concentrates on how costs and benefits are distributed along the sup-
ply chain (Garcia-Yì et al., 2014). Few projects have already dealt with supply chain impact, 
on structure and performance, of co-existence and segregation measures (e.g., the EU FP6 
projects SIGMEA and CO-EXTRA; see also Ghozzi et al., 2016); however, a more deep 
analysis of supply chain effects (e.g., on structure and relationships) is missing.  
Consumers’ attitude towards the use of new techniques in food production (e.g., new 
breeding techniques, nanotechnology – GMOs) needs to be investigated further. In fact, 
although most of what can be known by questioning on a hypothetical base has already 
been investigated (Dannenberg, 2009), research is missing on consumers’ acceptance stud-
ies using real settings. Further research efforts are needed to explore on the economic 
evaluation of the effects (positive and negative) of GMOs on the environment, using a 
multidisciplinary approach (Garcia-Yì et al., 2014). In this context, a comparative analysis 
of GM, organic and conventional crops in terms of environmental, social and economic 
sustainability, should be elaborated. 
At farm level, research usually evaluated the main economic effects of GM crops, such 
as yield, costs, gross margin (European Commission, 2011). More research is needed to 
study the economic implications of more efficient GM varieties, like second generation 
GMOs (e.g., nitrogen-efficient GM wheat), e.g., assessing how these GMOs move the yield 
frontier, how improvements in yield efficiency affect the economic performance of farm-
ers, etc. This research need is likely a transnational one, since not all the countries could 
have the same interest. Moreover, other socio-economic impacts are scarcely documented, 
such as the indirect effects arising from the GM crops management (e.g., how GM appli-
cations affect farm management planning, cropping system, crop rotation, etc.). Research 
should also study the differences between intensive and extensive margin effects (Bennett 
et al., 2013), the stability of new GM crops yields (e.g. draught resistant) on a mid- and 
long- term basis, and the economic performance of HT crops (Areal et al., 2012). 
Finally, the socio-economic group noted the need to develop systematic reviews and 
meta-analyses to consolidate existing knowledge, and to improve the communication of 
available evidence. In terms of communication, research is also needed to better under-
stand the key elements in stakeholders’ communication and interaction.
4.4 Human and animal health research needs
The “Human and animal health” working group distinguished research needs across 
all types of GM species. Major consideration related to the GM crops intended to be 
used as food and feed is whether they are safe for consumption, which should be evalu-
ated under the EU risk assessment frame. While there is substantial amount of experi-
mental data (e.g., feeding studies with laboratory and livestock animals) for the varieties 
which already exist on the market (Flachowsky et al., 2012; Snell et al., 2012; Ricroch 
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et al., 2014), a specific food safety concerns could emerge with the development of new 
types of GM crops such as plants combining several modifications (stacks) and GM plants 
with deliberately modified nutritional properties (Halford et al., 2014; Ramon et al., 2014). 
Specific health related questions were pointed by the stakeholders; for instance, the group 
agreed that research is needed to explore toxicity effects of multiple Bt proteins in in-vitro 
systems, the potential hypo-allergenicity of GM crops, and the definition of the minimal 
required inclusion level of plant-expressed phytase for efficient phosphorus utilization of 
animals. Traceability and post-marker monitoring are also among the stockholders con-
cerns; there is also a considerable lack of data on the traceability of specific GM crops, 
on verification of consumption and/or potential health impacts of GM food ingredients 
(e.g., GM crops with enhanced fatty acids), as well as on toxic substances produced by 
GM plants used in feed production (i.e. acetylated aspartic acid). 
Further, the group noted that little knowledge is available on the health effects of 
producing pharmaceuticals by the use of GM plants. While substantial progress has been 
made in the development of GM plants for molecular farming, still the scale remains rela-
tively small, mainly performed in laboratory or contained conditions. The major challenge 
is the legislative frame and the adaptation of the risk assessment principles to this plant 
biotechnology applications (Sparrow et al., 2013). The group agreed that a common fea-
ture of risk assessment of potential protein toxicity is needed (bioinformatics). A specific 
issue was raised for myco-toxins in Bt maize; research is needed to assess whether reduced 
fumonisin content can be found, as well as their potential and real benefits. Although 
there is a large body of knowledge available, there is a need to develop a systematic analy-
sis of the data collected by the regulatory bodies. 
GM plants producing RNAi molecules represent a biotechnological development 
which seems close to the EU market; therefore, experts have raised concerns over the 
potential health implications due to the technological differences with the first generation 
of GM plants. Steps towards the identification and evaluation of the specific human and 
animal health risk that may come with the new generations of GMOs and the adaptation 
of the regulations and risk assessment guidelines have already been taken by the scien-
tists, agencies and regulatory bodies (Petrick et al., 2013; Ramon et al., 2014). The “health” 
working group considered a number of research needs related to RNAi based plants, for 
instance more information is needed on survival and uptake in humans and animals, and 
post-market monitoring. Although it’s a corporate responsibility to deal with the commer-
cial production and marketing, the EU authorities must provide the appropriate methodol-
ogy and tools for their monitoring along the whole supply chain. An example for this is 
the database on food consumption of the EU Member States that is being collated by the 
EFSA. The same is needed for feed ingredients. Allergenicity is commonly considered for 
humans, whereas there is only limited knowledge available on the impact on farm animals. 
This type of investigation should also explore possible links with post-market monitoring. 
Finally, there is still uncertainty about the potential for horizontal gene transfer of 
genetically modified micro-organisms (GMMs) and viral DNA. Although this concern has 
been investigated and discussed in the past (Dröge et al., 1998; Keese, 2008), stakeholders 
pointed that better methods need to be developed to assess the presence and diffusion of 
recombinant DNA and cells.
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4.5 Environmental research needs
The “Environment” working group determined that the research needs can be priori-
tised according to the criterion of “ecosystem services” provision (Tscharntke et al., 2005). 
Such an approach would involve the monitoring of cultivated land (on-crop area), but 
also of the space between crops in a landscape (off-crop area), and analyse how these two 
different kinds of areas influence each other in terms of ecological functionality. In this 
respect, the need for comparative study of different Integrated Pest Management (IPM) 
systems used in the EU Member States was highlighted, as well as the need to assess the 
role that GMOs (plants and insects) might play in such IPM systems (Hokkanen, 2015). 
Moreover, efforts should be directed to study the efficacy of GMOs in different GM events 
which hold promises of relevant economic and environmental benefits, such as blight 
resistance potato (Haverkort et al., 2016), and to a deeper understanding of the develop-
ment dynamics of insecticidal protein resistance mechanisms in target insects (e.g., corn 
borers, etc.). 
Additionally, regulating and supporting services (pollination, pest control, soil fertility 
maintenance, etc.) were considered. The experts concluded that goals for the protection 
against undesirable effects have to be assessed at the landscape level. This type of moni-
toring, however, requires instruments to study the possible effects of different stressors, 
including GMOs, on key species and ecosystem services (e.g., on bees and wild pollina-
tors). System interfaces (i.e. land and water) were also defined as important points to 
explore further, as well as the change of dynamics in the system over time. More informa-
tion on species assemblages before introduction of GM crops, to define appropriate base-
line indicators, is needed for plants, arthropods and micro-organisms (e.g., soil indicators) 
(van Capelle et al., 2016).  
Further, the protection of cultural services was discussed (e.g., how people perceive 
agriculture, recreation, psychological benefits from contact with nature, etc.). Research is 
needed to study biodiversity in protected areas from different perspectives, in particular 
to qualify what type and level of biodiversity that society would like to maintain locally. 
Cropping practices (i.e. weed control efficiency) may have indirect effects on nearby val-
ued areas. For instance, the elimination of weeds by farmers on their fields has also an 
impact on the trophic level in terms of available resources for sap feeders, pollinators, nat-
ural enemies, etc., that may in turn affect the functional biodiversity of neighbouring areas 
and need to be investigated further (Bürger et al., 2015). In general, there is also a need 
to study the people’s perception of different agricultural systems, and this should ideally 
involve both the natural and the social sciences (multi-disciplinary research).  
Finally, the group included research needs not strictly related to ecological services. 
There is strong support for looking more into automated and harmonized methods for 
general surveillance, for studying non-target effects of new modes of action (e.g., RNAi) 
(Lundgren and Duan, 2013), and for new traits and breeding techniques on the envi-
ronment. There are still knowledge gaps about the traceability and environmental fate 
of GMMs, and to develop bioinformatic tools for studying their evolution in the system. 
Finally, there is also limited knowledge about the effects of GM arthropods on the environ-
ment, and this is also an area characterized by quickly progressing of genomic technologies 
for possible applications in agricultural as well as in human diseases prevention projects. 
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5. Results: requirements for sharing capacities and infrastructures
The main requirements for sharing existing (national) capacities and infrastructures 
were identified during the working groups’ activities. 
The “Human and animal health” working group found that in various countries there 
is a high level of expertise available for studying the hypo-allergenicity of GM crops which 
needs to be shared. Harmonization and joint initiatives are possible for sharing experiences 
on the traceability of specific GM crops. Since applications for RNAi-expressing crops have 
been mostly developed outside the EU, and limited expertise is available at the EU level, the 
group concluded that a transnational organization of capacities would put the EU in a posi-
tion to overcome this deficit in the future. As a lot of research has been done on peptide (e.g., 
cytotoxic peptides, food peptides) and their physiological effects (e.g., dairy research, antibiot-
ics), the group defined the need to integrate these research capacities available across certain 
EU countries and sectors, for the purpose of assessing potential protein toxicity as another 
important study area. For the assessment of allergenicity in farm animals there are probably 
only limited capacities available at the EU level, and future research would also benefit from 
transnational organization of resources. A high level of expertise for GMMs and viral DNA 
horizontal gene transfer was found in various EU countries; again, the relative research needs 
are invited to be organized transnationally to increase the overall efficiency. 
The “Environment” working group defined requirements for sharing controlled exper-
imental field sites throughout Europe, to allow GMO field testing on representative envi-
ronments of the various European settings. The fields could also be used to avoid several 
regulatory constrains which make it difficult for public research in Europe to study the 
effects of GMOs. The group discussed the necessity to have meso-cosm facilities for soil-
based experiments. The group concluded that calls for multi-/inter-disciplinary actions 
and projects should invite applications that combine different technologies/methods 
of scientific enquiry. Finally, it was felt that the GM regulatory, testing and monitoring 
methods should be harmonised, as much as possible, with other, similar methods and 
approaches in related areas (e.g., pesticide registration, international work on the valuing 
and monitoring of ecosystem services, etc.). 
The “Socio-economic” working group discussed the need to develop protocols and guide-
lines for conducting socio-economic impact assessments, which would ensure basic compat-
ibility of results, without sacrificing the flexibility of approaches in the process. Similarly to 
the “Environment” group, they also highlighted the need to share field trials, and to develop 
more field studies for assessing yields, costs, and other economic aspects of the use of GMOs. 
In addition, the need to develop multidisciplinary tasks capable of taking qualitative research 
(e.g., socio-psychology, behavioural economics, etc.) into account, was included in the list of 
priorities. Finally, the group concluded that researchers’ capacities should be shared, via train-
ing and staff exchange programs, thus developing ways to facilitate future collaboration among 
researchers from different countries (e.g., sharing capacities, PhD programmes, etc.).
6. Conclusions 
This paper aims to promote a critical debate among relevant stakeholders and policy 
makers by identifying future research directions in the evaluation of environmental, health 
74 D. Menozzi
and socio-economic effects of current and emerging applications of GMOs. The outcome 
of the international workshop, which was the follow up of a mapping exercise of existing 
research activities in Europe, is a list of perceived transnational research needs and con-
sequent requirements for sharing existing capacities and infrastructures; it therefore rep-
resents more than a generalized description of research trends. The list of research needs 
will allow those developing research plans to focus more deeply on one or a few themes 
that were deemed more relevant by the scientific community as well as the European risk 
managers’ network. This process may provide a basis to develop a prioritization from the 
perspective of the diverse group of stakeholders, which is to be developed in a next step of 
the project. The results of the PreSto GMO ERA-Net project formed the basis for a joint-
ly prepared strategic plan and roadmap for the implementation of the ERA-Net that will 
coordinate transnational research on the effects of GMOs (Rauschen et al., 2015). 
As pointed by Twardowski and Małyska (2015), the slow progress in the EU decision 
making process forced several biotech companies to move R&D and applied activities to 
other regions, thus reducing personnel in the EU and transferring existing know-how out-
side the EU. Moreover, this prevented the commercialization of innovative GMOs, possi-
bly resulting in competitive disadvantages for European farmers (Park et al., 2011). Future 
directions of socio-economic research on the effects of GMOs should primarily con-
sider the development of a methodological framework for analysing the socio-economic 
effects of GMOs. An assessment of the welfare effects across different groups in society 
may assist the definition of more informed policies. The research questions related to the 
effects of newly emerging GMOs to human and animal health raised by the stakehold-
ers during the workshop were general in many occasions or rather case specific in others. 
While some of them might be found relevant for the risk assessment to different extend, 
others are related to traceability and post-market monitoring, and some could appear 
to be within the scope of the risk assessment frameworks to be developed for the new 
GMOs, such as RNAi plants. The environmental research needs identified were prioritised 
according to the criterion of “ecosystem services”, involving the monitoring of on-crop 
and off-crop land area, and how these two different kinds of areas influence each other 
in terms of ecological functionality. The emerging applications, as well as the tendency 
of GM developers to combine different traits to produce new commercial varieties (the 
so-called “commercial stacks”) (Parisi et al., 2016), pose relevant questions to researchers, 
risk assessors and policy makers on how to adapt the EU regulatory framework consider-
ing the environmental and health-related issues, as well as the socio-economic dimensions 
(e.g., international trade) when making decisions on GMOs. 
A key factor in implementing this process will be the confidence that those planning 
and funding research have in the method used (Schneider and Gill, 2016). The activi-
ties described in this paper has explicitly taken into account the wider views of a diver-
sity of stakeholders and end-users (i.e. industry, farming organisations, CSOs, NGOs, 
EU and national competent authorities, funding organisations, academia). This intended 
to encourage participation of different scientific communities (scientists from all over 
Europe) in the future joint transnational calls managed through the ERA-Net, to enhance 
collaboration between actors (to leverage complementarities) and to increase the account-
ability of research trajectories and outcomes (create an internationally recognizable criti-
cal mass). The decision to consider a single group of 20 participants allowed balancing 
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the greater diversity of technical and sector perspectives, and the facilitation of more fluid 
working involvement from all participants. Breakout groups allowed the experts to elab-
orate on a greater number of details surrounding the interfaces of their disciplines with 
others, and this can thoroughly inform the scientific community in planning and promot-
ing interdisciplinary and transdisciplinary research (Powers, 2014). Viewed from the per-
spective of group dynamics, the entire process aimed to achieve a common understanding 
of the research gaps and needs in the evaluation of current and emerging applications of 
GMOs able to design future research directions. 
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